Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR009063)
Formula
SVG example
Unclear
Reactant Bevacizumab + Trastuzumab Product Glyco-LCA (GLCA)
Reactant Info Product Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR009057 Bevacizumab + Trastuzumab 3-Keto-lithocholic acid(3KLA) Unclear - Unclear Bevacizumab + Trastuzumab [1]
MR009064 Bevacizumab + Trastuzumab Tauro-LCA (TLCA) Unclear - Unclear Bevacizumab + Trastuzumab [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004569 Inositol D-Glucuronic acid Unclear Inositol [3]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004570 D-Glucuronic acid D-xylulose-5-phosphate Unclear Inositol [3]
References
1 The metabolism of lithocholic acid and lithocholic acid-3-alpha-sulfate by human fecal bacteria
2 Inhibition of Human Sulfotransferase 2A1-Catalyzed Sulfonation of Lithocholic Acid, Glycolithocholic Acid, and Taurolithocholic Acid by Selective Estrogen Receptor Modulators and Various Analogs and Metabolites
3 Potential role and therapeutic interests of myo-inositol in metabolic diseases

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.